PROCTER & GAMBLE HEALTH LTD - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended March 31,2022 And Interim Dividend For The Financial Year 2021-22

Rediff Moneywiz

Hi Guest
Feedback

Procter & Gamble Health Ltd - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended March 31,2022 And Interim Dividend For The Financial Year 2021-22

Download	< Back
05 May 2022
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (commenced at 6:00 p.m. and ended at 7: 20 p.m.), the Unaudited Financial Results for the quarter ended March 31,2022 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended March 31, 2022; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended March 31, 2022 furnished by Statutory Auditors of the Company Further, we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended an Interim Dividend for the Financial Year 2021-22 of Rs. 41 per Equity Share (Face Value of Rs. 10/- each). The dividend shall be paid on or before May 31, 2022.
View all announcements for Procter & Gamble Health Ltd	Source: BSE India

ALL MONEYWIZ PAGES